ArticleFrontiers in medicine2023

Phase III, randomized, double-blind, placebo-controlled clinical study: a study on the safety and clinical efficacy of AZVUDINE in moderate COVID-19 patients.

Sávio Bastos de Souza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.